SCRI Research Symposium

Office for Teaching, Education and Research (OTER) at Seattle Children's Research Institute

5th Annual Research Symposium for postdocs and students at Seattle Children's Research Institute. 

For those who don't have independent zoom links, please connect via this link:
https://us02web.zoom.us/j/81010577982?pwd=TTB1d2ZhQnlUdUVXWTlyU2hsdmsvdz09 


More info: https://scriresearchsymposium

Filter displayed posters (11 keywords)

Show Posters:

Modeling kinase networks involved in peroxisome biogenesis via single-cell colocalization and morphology metrics

Therese M. Pacio, Fred D. Mast, and John D. Aitchison

Abstract
Peroxisomes play an integral role in human health. Dysfunction in peroxisome biogenesis can compromise overall peroxisome and cellular function and can lead to severe neuropathologies and metabolic disorders. While a spatiotemporal model of peroxisome biogenesis has been characterized in yeast cells, the extent of the conservation of this model in humans is unknown. Here we perform Kinase Regression Analysis (KiR) using single-cell features extracted from microscopy datasets to deconvolve kinase networks involved in peroxisome biogenesis. Huh7 cells with a KiR panel were fixed and stained for Pex3, Pmp70 and Sec61 to capture Pex3 colocalization at both early and late stages of peroxisome biogenesis. Primary pediatric hepatocyte cells donated by two patients were also stained for Pex3, Pmp70, and actin. CLARITY, a python-based image analysis pipeline, was used for single-cell feature extraction from the image datasets. Images were stacked into multi-channel 3D arrays and restored via deconvolution. Images were then cropped to center the in-focus z-plane and an average array of the 3 image channels was generated in preparation for image segmentation. The Allen Institute’s deep learning based cell segmenter and structure segmenter were employed to binarize and identify single cells and peroxisomes in the images. Finally, colocalization and peroxisome morphology features were extracted from the images and inputted into the KiR algorithm to predict kinases involved in peroxisome biogenesis. Morphometric analysis of peroxisomes show high variation in peroxisome volume, intensity and number per cell, demonstrating multiple states of peroxisome biogenesis present in a single treatment. Population distributions of Pearson’s Correlation Coefficients demonstrate varying distributions of colocalization between Pex3 and Pmp70 as well as Pex3 and Sec61 in response to different kinase inhibitors. Multiple wells showed multimodal correlation distributions, demonstrating the presence of multiple states of colocalization within a single treatment. Colocalization metrics were binned and inputted into the KiR algorithm. For each bin, 35-45 kinases were identified and hypothesized to alter Pex3 colocalization. The pairing of single-cell image data extraction with KiR analysis demonstrates a novel method of modeling kinase networks. Future work includes performing validation experiments to verify the predictions of kinases involved in peroxisome biogenesis.
Presented by
Therese Pacio
Institution
Center for Global Infectious Disease Research
Keywords
CGIDR, 1:00-1:30

Association between eyes closed resting state alpha EEG power and social responsiveness in youth with and without ASD: The GENDAAR Study

Milana Premkumar, Megha Santhosh, MHA, Kevin Pelphrey, PhD, Sara Jane Webb, PhD, Emily Neuhaus, PhD, & the GENDAAR Consortium

Abstract
Background:  Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by deficits in communication, and social impairments. Alpha power, EEG activity between 8 and 12 Hz, is found present during quietly resting with greater power (amplitude squared) when the individual’s eyes are closed than when eyes are open. This is thought to reflect increased cortical activation (decreased power) when eyes are open in preparation for attention and cognition (Klimesch, 2012). Previous research has found lower alpha power in individuals with ASD compared to typically developing (TD) (Neuhaus et al., 2021, review Wang et al, 2013) and has been associated with attention and cognition and social understanding and imitation in individuals with ASD (Neuhaus et al., 2021; Perry et al., 2011). Objective: To evaluate association between eyes closed EEG resting state alpha power and social responsiveness in youth with and without ASD by gender and diagnosis.    Methods: Data were collected from 152 youth (ASD = 76) ages 8-17 years, from an NIH funded study investigating sex and gender differences in youth with ASD. Youth sat with eyes closed while high density EEG data was collected. Data were processed per Neuhaus et al. (2021). A fast fourier transformation (FFT) was applied to artifact free EEG data to extract alpha power for central and posterior electrodes. Regions of interest (ROIs) for alpha power were calculated over: left frontal (LF: 23, F3-24, 27, 28), mid frontal (MF: 5, FZ-11, 12, 16), right frontal (RF: 3, 117, 123, F4-124), left central (LC: 35, 36, 41, 42); left posterior (LP: 51, P3-52, 59, 60) mid central (MC:7, 31, 80, 106); mid posterior (MP: 62, 71, 72, 76); right central (RC: 93, 103, 104, 110); and right posterior (RP: 85, 91, 92, 97). Parents of children completed the Social Responsiveness Scale-2 (SRS-2) which is a 65-item rating scale measuring autism traits. A series of one-way ANOVAs and correlations were conducted to evaluate the differences in frontal, central and posterior alpha power x group (ASD/TD), gender (male/female) and associations with social responsiveness. We previously report on EEG alpha power during eyes open calm viewing (Neuhaus et al., 2021) and extend this work to the eyes closed resting condition.   Results: Preliminary analysis shows significant main effect of diagnosis for eyes closed alpha power in LF, MF, RF, LC, MC, MP, RC and RP regions (F(1,150)s > 6.14, ps < .05). No significance was observed for the LP region (F(1,150 2.17, p = .14). Power was significantly lower in the ASD group compared to the TD group. Within the ASD group, correlations between the SRS total score and alpha power was non-significant for any regions, including the SCI subscale (p = > .05).   Conclusions: Initial findings are consistent with prior research suggesting alpha power is reduced in youth with ASD when compared to TD, and extends this work to EEG acquired during eyes closed. No significant correlations were observed with SRS-2 parent report of autism traits. Additional analysis will include additional phenotypic correlates (Vineland and verbal/nonverbal IQ) and will examine relations by gender.
Presented by
Milana Premkumar <milana.premkumar@seattlechildrens.org>
Institution
Center for Child Health, Behavior and Development
Keywords
CHBD, 1:00-1:30

Siglec 9 is expressed on human mast cells and decreases their inflammatory potential

Irina Miralda, PhD; Nyssa B. Samanas, PhD; Adrian M. Piliponsky, PhD

Abstract
Mast cells (MC) are granule-containing immune cells that primarily reside at mucosal surfaces and the skin. MC are strategically poised to initiate immune responses to allergic and pathogenic threats by releasing an impressive arsenal of proteases, cytokines, chemokines, and other inflammatory mediators. As major effector cells of inflammation, the activation of MC must be tightly regulated, and one type of inhibitory receptor on MC are Sialic acid-binding immunoglobin-like lectins (Siglecs). Siglecs are type I transmembrane lectins that are characterized by the presence of an N-terminal V-set immunoglobin domain that binds sialic acid and a C-terminal cytoplasmic region that typically contains one or more immunoreceptor tyrosine-based inhibitory motifs (ITIM) that dampen immune cell activation. Human MC express Siglec 2, 3, 5, 6, 7, 8, and 10. Ligation of Siglec 6, 7, or 8 prior to stimulation by IgE results in decreased activation of MC and, subsequently, decreased release of pro-inflammatory mediators. Siglec 9 is expressed on neutrophils, monocytes, B cells, and NK cells and plays an important role in limiting the baseline activation of these immune cells. A high throughput screen of lung MC detected Siglec 9 on their surface, but this result was not validated, and it is unknown whether Siglec 9 plays an important role in MC functions. Thus, we hypothesize that MC express Siglec 9 and that signaling through this receptor can dampen the activation of MC. Our data shows that human MC lines LAD2, LUVA, and HMC-1 express high levels of Siglec 9 by mRNA and surface protein expression. Moreover, pre-treatment of LAD2 MC with Siglec 9 agonists Glycophorin A or High molecular weight hyaluronic acid (HMW-HA) followed by stimulation with IgE results in decreased release of granule content. These agonists showed no inhibitory effect against CRISPR/CAS edited LAD2 cells deficient in Siglec 9. Additionally, we tested whether human primary cells express Siglec 9 by using peripheral blood-derived cultured MC (PBCMC) as a model. The expression of Siglec 9 peaks at week 5 of differentiation of PBCMC and correlates positively with the expression of the high affinity receptor for IgE, FCƐRI. Interestingly, incubating PBCMC with IgE increased the expression of both FCƐRI and Siglec 9. Together, our data shows that human MC express Siglec 9 and that engaging this inhibitory receptor can reduce the immune cell’s activation. This is significant because targeting Siglec 9 may be a powerful tool to limit inflammation by dampening innate immune responses.
Presented by
Irina Miralda
Institution
Center for Immunity and Immunotherapies
Keywords
CIIT, 2:30-3:00
Chat with Presenter
Available Dec. 9, 2:30 p.m. - 3:00 p.m.
Join the Discussion

A New Path for CF Clinical Trials through the Use of Historical Controls

Mark Warden, MS, Amalia S. Magaret, PhD, Noah Simon, PhD, Sonya Heltshe, PhD, George Z. Retsch-Bogart, MD, Bonnie W. Ramsey, MD, Nicole Mayer-Hamblett, PhD

Abstract
Background: Clinical development of additional new CF therapies is challenged by smaller populations for whom significant treatment benefit is likely to be observed as access to ETI grows, impacting both the projected efficacy of a new therapy and the size of the optimal target population for development. Given future challenges in conducting large randomized, placebo controlled trials for future CF therapeutics development, we evaluated the potential for using external historical controls to either enrich or replace traditional concurrent placebo groups in CF trials.

Methods: The study included data from sequentially completed, randomized, controlled clinical trials, EPIC and OPTIMIZE respectively, evaluating optimal antibiotic therapy to reduce the risk of pulmonary exacerbation in children with early Pseudomonas aeruginosa infection. EPIC and OPTIMIZE both enrolled CF children with new onset Pa having similar eligibility criteria. The primary treatment effect in OPTIMIZE, the risk of pulmonary exacerbation associated with azithromycin, was re-estimated in alternative designs incorporating varying numbers of participants from the earlier trial (EPIC) as historical controls. The historical controls were incorporated using: (1) Pooling: combining all available participants from both studies to increase the size of the OPTIMIZE control group, (2) Augmenting: omitting half the OPTIMIZE participants randomized to placebo and augmenting the OPTIMIZE control group with all EPIC historical controls, (3) Replacing: omitting all OPTIMIZE participants randomized to placebo and replacing with all EPIC historical controls. Bias and precision of these estimates were characterized. Propensity scores were derived to adjust for baseline differences across study populations, and both Poisson and Cox regression used to estimate treatment efficacy.

Results: To standardize eligibility for this study, subjects <1 year of age and >12 were removed from OPTIMIZE. Baseline characteristics of the two study populations were otherwise largely similar. There were some notable differences, however: OPTIMIZE participants were more likely to chronically use hypertonic saline (35.6% vs 4.3%), and modulators (10.5% vs 0.0%) due to the timing of the trial in relation to changing standard of care. A propensity score for study of origin was computed, which correctly classified 75% to 84% of participants, depending on method of incorporating controls. In the original OPTIMIZE trial, there was a significant 44% reduction in risk of PEx associated with azithromycin as compared to placebo. Replacing 86 OPTIMIZE placebo participants with 304 controls from EPIC to mimic a fully historically controlled trial resulted an 8% reduction in risk of pulmonary exacerbations (HR:0.92 95% CI 0.61, 1.34) when not adjusting for key baseline differences between study populations. After adjustment, a 37% decrease in risk of exacerbation (HR:0.63, 95% CI 0.50,0.80) was estimated, comparable to the estimate from the original trial.

Conclusions: The potential exists for future CF trials to utilize historical control data. Careful consideration of the comparability of controls and optimal can reduce the potential for biased estimation of treatment effects.
Presented by
Mark Warden <mark.warden@seattlechildrens.org>
Institution
Center for Clinical and Translational Research
Keywords
CCTR, 2:30-3:00

Disparities in Access to Telehealth Services Among Gender Diverse Adolescents: Assessment of Seattle Children’s Gender Clinic Telehealth Visits

Ruby Lucas, MPH, Nicole Kahn, PhD, MEd, Kevin Bocek, BA, Diana Tordoff, MPH, Baer Karrington, MD, MScPH, Laura Richardson, MD, MPH, Gina Sequeira, MD, MS

Abstract
Background: The expansion of telehealth services during the COVID-19 pandemic has allowed for continued access to care for many patients, but little is known about whether it has removed or exacerbated existing barriers in access to gender-affirming care for transgender and gender diverse (TGD) youth. Hypothesis: The purpose of this study was to understand whether demographic characteristics of the TGD patient population receiving care in the Seattle Children’s Gender Clinic (SCGC) changed once telehealth services became available beginning in March 2020. Methods: We used electronic health record data to identify all patients who had an ICD-10 diagnosis of gender dysphoria and completed a medical visit at SCGC, either in-person or through telehealth, between March 2019-February 2021. Chi-squared analyses were used to assess differences in demographic characteristics and care utilization among those receiving care between March 2019-February 2020 (pre-telehealth) and March 2020-February 2021 (post-telehealth). We also tested for differences among those receiving care in the post-telehealth period after stratifying by telehealth and non-telehealth users. Results: Of the 1,061 unique patients during the study period (mean age at first visit: 15.6 years), 61.8% identified as transmasculine/male, 24.2% as transfeminine/female, and 7.8% as non-binary. The majority (67.7%) identified as non-Hispanic White, followed by Hispanic/Latinx (11%), Asian (3.2%), Black/African American (2.2%) and American Indian/Alaska Native and Native Hawaiian/Pacific Islander (0.8%). More than two-thirds (66.8%) resided within 35 miles of SCGC. Comparing the pre- and post-telehealth periods, a smaller proportion of patients identified using she/her and he/him pronouns and a greater proportion used she/they and he/they pronouns (p=0.007). Similarly, smaller proportions used all insurance types except for self-pay/charity care which increased post-telehealth (p<0.001). In the post-telehealth period, 48.6% of all visits were conducted via telehealth; however, there were no significant differences in telehealth utilization by demographic characteristics. Conclusion: Our findings indicate that demographic characteristics of SCGC patients remained relatively consistent with the introduction of telehealth services. Although this suggests that telehealth has not introduced new disparities in access to gender-affirming healthcare, the SCGC patient population continues to be disproportionately comprised of White privately insured patients living in urban areas, indicating ongoing disparities in access to gender-affirming care for youth of color and rural youth. Overall, these findings improve our understanding of how telehealth has affected access to gender-affirming care and can be used to advocate for evidence-based policies to improve healthcare delivery and reduce health inequities among TGD youth.
Presented by
Ruby Lucas
Institution
Center for Child Health, Behavior and Development
Keywords
CHBD, gender care, telehealth, 1:00-1:30
Chat with Presenter
Available Dec. 9, 1:00 p.m. - 1:30 p.m.
Join the Discussion

Evaluating the Feasibility and Acceptability of Using Ecological Momentary Assessment For Psychiatric Services During the COVID-19 Pandemic

Yesenia Garcia, B.A., Cindy Ola, PhD, Brent Collett, PhD, Freda Liu, PhD

Abstract
Background: Ecological Momentary Assessment (EMA) is a tool that is well used in research to gather information remotely from individuals about their mood, behaviors, and symptoms in real time. Utilizing remote assessment became increasingly important as a result of social distancing guidelines. Preliminary data about the feasibility and acceptability of using EMA as part of psychiatric outpatient therapy services during the COVID-19 Pandemic are discussed in this abstract.

Hypothesis: We hypothesize that EMA will be a feasible and acceptable method for use in outpatient psychiatry groups.

Methods: Spanish and English-speaking parents and their children who were enrolled in 1 of 6 outpatient psychiatry groups at Seattle Children’s North Clinics were invited to participate in the study. After informed consent was obtained, participating families downloaded the Metric Wire application, designed for EMA data collection. Families received EMA notifications to complete a survey between 2-3 times per week on either a specified time designated by the participants or on randomly selected days throughout the week. EMA questions asked about the child’s mood, behavior or a specific parenting skill used on a particular day. Participating families and clinicians completed semi-structured qualitative interviews to obtain feedback about the acceptability of these procedures as part of outpatient psychiatric care.

Results: 15 families enrolled in the study. 47% of participants were Caucasian, 33% were Hispanic, and 20% were Asian/Pacific Islander. 27% of participants were primarily Spanish-speaking families. On average, families responded to 55% of EMA surveys. Based on the qualitative interviews, participating families reported that each EMA survey served as a “reminder” to utilize one of the parenting skills taught in their outpatient group. Based on qualitative interviews with clinicians, they expressed difficulty in incorporating EMA as part of their outpatient psychiatry group. Challenges centered around the time-commitment and remembering to review the EMA surveys for each family participating in the study.

Conclusions: Preliminary data indicates that EMA is acceptable to families but there are issues with feasibility that may pose a challenge for integration in outpatient psychiatry services. Our findings will provide recommendations for overcoming feasibility challenges and recommendations for future iterations of EMA procedures in clinical care.
Presented by
Yesenia Garcia
Institution
Center for Child Health, Behavior and Development
Keywords
CHBD, 1:30-2:00
Chat with Presenter
Available Dec. 9, 1:30 p.m. - 2:00 p.m.
Join the Discussion

Ki67, CXCR3, and CCR6 antibody labeling of hepatic T cells in naïve and SIV-infected macaques

Yohannes M. Abraham, Katherine A. Fancher, Nina Derby, PhD, Donald Sodora, PhD

Abstract
Background: During HIV infection, liver disease is a major cause of morbidity and mortality even in individuals treated with combination antiretroviral therapy (cART), but its pathogenesis is not completely understood. The simian immunodeficiency virus (SIV), infection of rhesus macaques, represents an optimal research model, as SIV is genetically related to HIV and results in similar pathology. Using this animal model, we are able to collect repeated laparoscopic liver biopsies, allowing for a longitudinal evaluation of immune cell subsets during SIV infection. Previous research found an increase in CD8+ T cells in the liver during SIV infection as well as a correlation between Ki67+ (replicating) T cells in the bloodstream and gastrointestinal tract of macaques. CXCR3+ T cells have been shown to be associated with T cell recruitment to inflamed and infected tissues, while CCR6+ T cells are associated with wound healing and fibrosis. We hypothesized that early in SIV infection, T cells would be replicating locally and thus we expected to find more hepatic T cells expressing Ki67 than before infection or in samples from naïve macaques. We further hypothesized that T cell recruitment and inflammation would be evidenced by an increased number of hepatic CXCR3+ T cells early in SIV infection. Finally, we predicted to find a greater number of CCR6+ T cells during late-stage SIV infection, which is associated with liver fibrosis.

Methods: Liver biopsies from rhesus macaques were fluorescently labeled for CD3 (T cell), Ki67, CXCR3, and CCR6 antibodies. CD3+ Ki67+ cells were analyzed in naïve and SIV+ animals at baseline (week 4 before infection) and acute/early infection (week 2 after infection). Both CD3+ CXCR3+ and CD3+ CCR6+ cells were investigated at acute infection and necropsy (week 15-32 after infection). Immunofluorescence analysis was performed with Keyence BZ-X710 microscope. Computational analysis was conducted using Fiji/Image J, to quantify the percentage of hepatic Ki67+, CXCR3+, and CCR6+ T cells. GraphPad Prism was used to plot the results and perform statistical analyses.

Results: During acute SIV infection, the expression of Ki67+ T cells in all SIV-infected macaques was significantly higher than at baseline (P< 0.0001) and in naïve samples (P< 0.0001). Two SIV-infected macaques had a greater proportion of CXCR3 at necropsy compared to week 2, while two other SIV-infected macaques showed the opposite trend. In the CCR6+ subset, the same relationship was observed, however not for corresponding animals. Overall, comparing week 2 and necropsy, in the SIV cohort there was no significant change of expression of both CXCR3+ and CCR6+ T cells. At week 2 and necropsy, CXCR3+ T cells averaged 45% and 40%, respectively, whereas CCR6+ T cells averaged 10% and 11%, respectively.

Conclusion: Our findings indicate that hepatic T cell replication in SIV-infected macaques increases in early infection compared to baseline and in naïve samples. Contrary to our hypotheses, there was not a significant difference in the proportion of hepatic T cells expressing CXCR3 and CCR6 early and at late stage SIV infection. Further investigation will assess CXCR3+ and CCR6+ T cells at baseline and intermittent timepoints between week 2 and necropsy. In addition, more research will quantify CXCR3+ and CCR6+ T cells within the CD4+ and CD8+ T cell populations.
Presented by
Yohannes M. Abraham
Institution
Center for Global Infectious Disease Research
Keywords
CGIDR, 2:00-2:30
Chat with Presenter
Available Dec. 9, 2:00 p.m. - 2:30 p.m.
Join the Discussion

Attitudes and Engagement: The Use of AI Feedback and an Online Office for Treating ADHD Patients

Jessica M. Monroy, Sibley H. Margaret, PhD

Abstract
Background Therapists and supervisors use LYSSN, an AI-based tool that provides feedback on therapy audio tapes, and Care4 (a dashboard that provides supervisors with a library of resources for preparation of their clients and treatment manual). These online systems help support the implementation of STAND, (Supporting Teens Autonomy Daily), an evidence-based practice modular therapy that allows families to choose activities that target ADHD (Attention Deficit Hyperactivity Disorder) symptoms that focus on building skills as: academic, interpersonal, and planning with goal settings and implementation to help reduce ADHD symptomatology. The implementation of STAND is a cost-effective manner to implement evidence-based practices compared to the usual-care psychological services and medication. The purpose of this study is to demonstrate the utilization of resources on an online system and attitudes of therapists and supervisors when interacting with LYSSN and Care4 to implement STAND. Methods From a collection of four supervisors and six therapists, each therapist having a minimum of one patient and at maximum two patients, I use 49 therapist sessions and 3 supervision sessions to determine the attitudes and engagement. Therapists would login onto the Care4 system after a therapy session and answer questions about feedback they received from LYSSN and the preparation for their session. Supervisors could use the data collected from the therapist’s LYSSN score and formulate their feedback. Results On average it took supervisors 48.6 days to upload their tapes after having their sessions. 33% of supervisors would upload their session tapers within 48 hours. Therapists would take on average 10.9 days to upload their tapes after having their sessions. 25% of therapists would upload their session tapes within 48 hours. There was an average of 1.4 (SD = .77; 1= no time to 4-more than thirty minutes) for therapists reviewing feedback from their supervisors. 1.7 (SD = 1.2) for seeking consultation from the STAND research team. 1.9 (SD = .83) for reviewing feedback from LYSSN. 2.8 (SD = .93) for watching STAND demonstration videos. 3.2 (SD = .69) for preparing client worksheets. 3.4 (SD = .54) for reading through STAND descriptions. 2.8 (SD = .84; 1 – never to 5 – always) when it came to finding feedback credible. 2.7 (SD = .8) when it came to therapists finding their feedback to be accurate in summarizing their actions in their session. 3 (SD = 0; 1 – much easier to 5 – more difficult) to indicate the difficulty of supervision in comparison to their typical cases. 3.3 (SD = .57; 1 – very uncomfortable to 5 – very comfortable) in the comfortability of providing supervision. 1.6 (SD = .57; 1 - being not at all to 5 – being very much) from the extent supervisors would incorporate LYSSN feedback. 2 (SD = 1) from how credible LYSSN feedback was. 2 (SD = 1) from how useful LYSSN feedback was to provide supervision feedback. 3.6 (SD = .57) from how receptive the therapist was to feedback. Discussion Collection of this research will provide insight about the implementation of STAND through an online format and about the general appeal of the use of AI to provide feedback to therapists and help supervisors with the feedback they provide. Using AI feedback, the workload of supervisors and therapists could be reduced and give feedback more efficiently to them with regards to STAND treatment and other evidence-based treatments.
Presented by
Jessica Monroy <jmonroy@uw.edu>
Institution
Center for Child Health, Behavior and Development
Keywords
CHBD, 2:00-2:30
Chat with Presenter
Available Dec. 9, 2:00 p.m. - 2:30 p.m.
Join the Discussion

Digital Health Equity

Jordyn Warner and Arti Dilip Desai, MD, MSPH

Abstract
Background: Families who speak a language other than English have not been considered in the design of existing digital health technologies. The way in which we have designed these technologies do not cater to every family, which means they cannot recognize the benefits of these technologies for improving family-provider interactions. Purpose/Objective: To analyze and examine the health information technology disparities within Seattle Children’s and how it affects families whose first language is not English. Design/Methods: We conducted 25-minute interviews with families of patients hospitalized at Seattle Children’s Hospital (SCH) whose preferred language for medical communication is not English. The interview consisted of questions relating to how families access the SCH’s patient portal, how accessible interpreter services are, and how they connect to SCH providers from home. Our team also created login prototypes exhibiting various methods of logging into patient portals and helpline prototypes to triage questions from patients to their providers. We presented families scenarios in which they would give responses to how they would contact providers and any difficulties with telehealth services they have faced throughout their stay at Seattle Children’s. Results: We spoke to two Spanish speaking families, one Somali speaking family, and one Persian family that was conversational in English. All of the families stated that they do not use MyChart to contact their providers due to the difficulty and lack of understanding with the tool. On average it took 20 minutes to connect with their provider through interpreter services. 50% of the families have another person (e.g. child, spouse, family member) call in lieu of themselves to make their child's appointment. 75% of the families preferred login three (see figure 1) because the icons for passcode were easier to understand. The families chose to use the phone option for the helpline because it would be easier to call their providers and less error would occur over the phone (see figure 3).

Conclusion/Discussion: Health information technologies are an ongoing issue in healthcare. Further methods of reducing these issues need to be put in place to break down this barrier to promote equity within hospitals.
Presented by
Jordyn Alyssa Warner <jordynwarner0830@gmail.com>
Institution
Center for Child Health, Behavior and Development
Keywords
CHBD, 1:30-2:00
Chat with Presenter
Available Dec. 9, 1:30 p.m. - 2:00 p.m.
Join the Discussion

Assessment of follow-up rates after urinary incontinence diagnoses in pediatric populations

Taylor Washington and Kathleen Kieran MD, MSc, MME

Abstract
Purpose: Determine the association between patient sociodemographic variables and follow up rates at Seattle Children’s hospital. We hypothesized that children that were white, non-Hispanic, and spoke English would have the highest follow up rates with providers regardless of diagnoses.

Materials and Methods: We compiled data from January 2017-March 2017 and January 2018-March 2018 in a retrospective medical review of outpatients seen through the Seattle Children’s healthcare network. Demographic information, voiding concerns, and percentage of follow up rates within the time frames given by providers were assessed. Data was analyzed using SAS version 9.3 (Cary, NC). Findings were considered statistically significant at p<0.05.

Results: Patients who used an interpreter and had a long distance to travel for follow up were unlikely to return to the clinic within their clinically suggested time frame. Patients at or below the poverty level had statistically significantly different follow up rates when compared to patients of higher incomes regardless of diagnoses. Odds ratio of Black patients being told to return for scheduled follow-up versus white patients: 7.3 (95% CI: 1.3, 40.0); for Asian patients vs white 1.75 (0.39, 7.9), for American Indian patients versus white 2.4 (0.12-48.0). Odds ratio of patients with LOE being told to return for follow up compared with English-speaking patients: 1.54 (0.57-42). If given appointment recommendation, patient was 6.2 times as likely to return for follow-up visit (2.1, 12.5). None of the Black patients who were told to follow-up as needed followed up at all, whereas 19.2% of the white patients did. Of patients told to follow up, 80% of white patients did and 100% of Black patients did.

Conclusions: Race affected follow up rates for patients who visited the urology clinic. Specific recommendations from providers for follow up also led to increased rates of follow up at recommended rate times regardless of race or diagnoses. Further research should include a larger demographic of patients over a longer period of time.
Presented by
Taylor Washington
Institution
Center for Child Health, Behavior and Development
Keywords
CHBD

Targeted Ndufs4 KO in PV interneurons is sufficient to produce a mild LS-related epilepsy phenotype in mice

Devika Gandhay, Arena Manning, Elizabeth Chen, Rainelle Nevers, Franck Kalume PhD

Abstract
Background: Leigh Syndrome is a pediatric neurodegenerative disease that predominantly affects infants. It is associated with loss-of-function mutations in NADH-ubiquinone iron-sulfur protein 4 (NDUFS4) which resides within Complex I (CI) of the electron transport chain. The conditional knockout (KO) of Ndufs4 in only GABAergic interneurons leads to a severe epilepsy phenotype, suggesting GABAergic interneurons drive the severe and often fatal epilepsy phenotype which is commonly reported in patients. This present study aims to target a subtype of GABAergic interneurons called parvalbumin (PV) interneurons which display fast spiking firing patterns and are known to be expressed in the cortex and hippocampus, key regions often associated with epilepsy.

Hypothesis: We hypothesized that since PV interneurons display fast spiking patterns, the Ndufs4 KO will impair these cells, leading to severe spontaneous seizures, cell loss, and neurocognitive impairments.

Methods: Experimental mice models with Ndufs4flx/flx/PVCreflx/+ genotype for the mutants, and Ndufs4flx/flx/PVCre+/+ genotype for the controls were used in all of the experiments except imaging. For imaging experiments, Ndufs4flx/flx/Ai14flx/+/PVCreflx/+ were used for mutants and Ndufs4+/+/Ai14flx/+/PVCreflx/+ were used for controls.

For open field, mice of both genotypes were placed into a 50x50 cm open field chamber for 10 minutes and their movements were tracked. For EEG recordings, mice were implanted with EEG/EMG electrodes and placed in recording chambers where we assessed occurrence, frequency and duration of seizures and epileptiform events. For the PTZ challenge, mice were injected (subcutaneous) with 20 mg/kg PTZ and then placed in recording chambers for approximately 30 minutes where we assessed occurrence, frequency, and duration of seizures. For imaging, we counted Ai14-labeled PV interneurons in key areas associated with epilepsy (for example, cortex and hippocampus) between the two groups. Brains were harvested, sliced, mounted in triplicates, and imaged at 10X with a confocal microscope.

Results: PV mutants showed an increase in the frequency of myoclonic seizures and interictal spikes. There was no difference in seizure susceptibility (from the PTZ challenge) between mutants and controls. Additionally, we did not observe major impairments in locomotor activity nor anxiety like behavior in PV mutants. Finally, we did not detect cell loss changes in PV mutants.

Conclusion: These experiments show that PV mutants display a mild seizure phenotype, with no cognitive or motor abnormalities, suggesting targeted Ndufs4 KO in PV interneurons does not drive the severe epilepsy phenotype in LS.
Presented by
Devika Gandhay
Institution
Center for Integrative Brain Research
Keywords
CIBR, 2:00-2:30
Chat with Presenter
Available Dec. 9, 2:00 p.m. - 2:30 p.m.
Join the Discussion

Robotic Mosquito Dissection to Accelerate Malaria Research

Zephyr Pitre, Tess Seltzer, Christopher Sutanto, Samantha L. Brown, Thurston Herricks, Kamalakannan Vijayan, Veronica Primavera , Mikaela Follmer, Elizabeth K.K Glennon, Natasha Bourgeois, Scott E. Lindner, John D. Aitchison, Alexis Kaushansky

Abstract
We have created robots to automate the laborious task of dissecting mosquitoes and extracting malaria parasites. Producing malaria parasites is necessary for malaria research and vaccine development. Extracting even small quantities of the parasites by hand requires hours of difficult and tedious mosquito dissection, which limits the efficiency and extent of malaria research. Our team of scientists and engineers has built mosquito dissection and processing robots to automate parasite. Our robots dissect mosquitoes approximately eight times faster than by hand, and users can successfully dissect mosquitoes with significantly less training compared to manual methods. To test the usability of our robots, we sent to researchers at the Pennsylvania State University, who successfully dissected mosquitoes. In vitro studies of our robots show that the parasites produced are infectious but exhibit reduced immunogenicity when compared to hand dissected parasites. By replacing the inefficient process of dissecting mosquitoes by hand with our automatic dissection robots, we aim to remove a major barrier to researching malaria.
Presented by
Zephyr Pitre
Institution
Center for Global Infectious Disease Research
Keywords
CGIDR, 2:30-3:00
Chat with Presenter
Available Dec. 9, 2:30 p.m. - 3:00 p.m.
Join the Discussion